Overall, the Amphotericin B Prices online - $0



North America
During the fourth quarter of 2022, Amphotericin B Prices dynamics fluctuated in the North American region. Prices were expected to increase starting in Q4 2022 and continuing through the second month of the quarter as a result of a high cost of manufacturing, numerous logistical issues, and rising inflation. Rising transportation costs and port congestion at the key ports also helped to keep the market position strong. A slowdown in API output, disorganization, and rising energy prices all had a positive effect on the market. Due to easing inflation and reducing end-user sector demand, prices started to decline later in December 2022. Values were accessed at USD 6265400/MT CFR Houston at the end of Q4 with an average quarterly inclination of 0.40%.

During the fourth quarter of 2022, the Amphotericin B Prices in the Asia-Pacific region showed a general downward trend. Amphotericin B costs have decreased quarterly due to reduced demand from the terminal pharmaceutical sector. An economy that was slowing down, plentiful supplies, and plenty of stocks supported this consistent pricing pattern. Later in December, prices significantly dropped as a result of a dip in domestic and international market inquiries brought on by the approaching holiday and festive season. The market was also impacted by sufficient supply and inventory levels. Towards the termination of Q4 2022, the values accessed at USD 6150500/MT with a quarterly declination of 0.15%.

In the European market, Amphotericin B prices followed an uptrend in the fourth Quarter of 2022 amidst soaring energy coast and squeezed manufacturing profit margins. Values were accessed at USD 6383940/MT at the end of Q4 2022, with an average quarterly incline of 0.61%. Inflation in the eurozone was recorded to reach a new high of 10.7% in October from 9.6% recorded in September. The price of natural gas for household consumers soared, influencing the market situation. Also, increased production costs kept the market sentiments robust. Later, from the second month of Q4, the prices were witnessed to follow the stable trajectory on the stable back demand from the end-user sector and enough inventories among the domestic merchants.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of Chemanalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.